Peloton Wealth Strategists’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.39M Sell
1,161
-25
-2% -$25.5K 0.51% 57
2026
Q1
$1.09M Buy
1,186
+10
+0.9% +$10.1K 0.44% 60
2025
Q4
$1.26M Buy
1,176
+46
+4% +$44K 0.49% 63
2025
Q3
$862K Buy
1,130
+3
+0.3% +$2.23K 0.34% 71
2025
Q2
$878K Buy
1,127
+16
+1% +$12.4K 0.35% 68
2025
Q1
$918K Buy
1,111
+44
+4% +$36.6K 0.38% 67
2024
Q4
$824K Sell
1,067
-250
-19% -$207K 0.33% 67
2024
Q3
$1.17M Sell
1,317
-49
-4% -$44.1K 0.46% 63
2024
Q2
$1.24M Buy
1,366
+161
+13% +$129K 0.51% 60
2024
Q1
$938K Hold
1,205
0.38% 66
2023
Q4
$702K Buy
1,205
+1
+0.1% +$584 0.3% 69
2023
Q3
$647K Hold
1,204
0.3% 72
2023
Q2
$565K Buy
1,204
+1
+0.1% +$419 0.25% 72
2023
Q1
$413K Buy
1,203
+303
+34% +$102K 0.19% 74
2022
Q4
$329K Hold
900
0.16% 79
2022
Q3
$291K Hold
900
0.15% 80
2022
Q2
$292K Hold
900
0.14% 79
2022
Q1
$258K Buy
+900
New +$232K 0.11% 82

Other funds holding LLY

Peloton Wealth Strategists's LLY Position: Q2 2026 in Review

Peloton Wealth Strategists reduced its Eli Lilly (LLY) stake by 2.1% in Q2 2026, selling an estimated $25.5K and leaving 1,161 shares worth $1.39M. The position accounts for 0.51% of the portfolio, ranked #57.

Peloton Wealth Strategists first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Peloton Wealth Strategists held 1,161 shares of Eli Lilly worth $1.39M as of Q2 2026.
  • Peloton Wealth Strategists sold 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
  • Eli Lilly made up 0.51% of Peloton Wealth Strategists's portfolio in Q2 2026, its #57 holding.
  • Peloton Wealth Strategists first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Peloton Wealth Strategists's 13F filing for Q2 2026, filed 10 Aug 2026.